论文部分内容阅读
山东鲁抗医药集团有限公司是全国重点发展的六大骨干制药企业之一，我国重要的抗生素生产基地，国家大型（一）类企业，也是具有控股公司功能的、有独立法人资格的法人实体。进入“八五”，鲁抗公司以企业的股份制改造为契机，不断深化各项内部制度改革，建立健全母子公司...
Shandong Lukang Pharmaceutical Group Co., Ltd. is one of the six key pharmaceutical enterprises under development in China. It is an important antibiotic production base and a large state-owned enterprise in China. It is also a legal entity that has the function of a holding company and has independent legal personality. Entering the “Eighth Five-Year Plan”, Lukang Company takes the transformation of its shareholding system as an opportunity to constantly deepen the reform of its internal systems and establish a sound parent-subsidiary company.